Department of Botany and Microbiology, Female Campus, College of Science King Saud University, Riyadh, Saudi Arabia.
Bioprocess Engineering Division, Smykon Biotech Pvt Ltd, Nagercoil, Kanyakumari, Tamil Nadu, 629201, India.
J Infect Public Health. 2019 Nov-Dec;12(6):861-866. doi: 10.1016/j.jiph.2019.05.016. Epub 2019 Jun 24.
The occurrence of drug resistant infectious disease causing microbial pathogens was highly spreaded because of the wide level application of the commercially available antimicrobial agents. However, the eradication of the microbial pathogens was of huge demand. Although, many antimicrobial compounds were commercially available in the market however the spreading of the pathogens were hugely increased. Actinomycetes produce various secondary metabolites against pathogenic bacteria and fungi. The present investigation aimed to study the antimicrobial potential of the Streptomyces sp. towards infectious diseases causing pathogens.
Culture dependable isolation techniques were followed for the isolation of the active actinomycetes isolates and the antimicrobial properties of the actinomcyetes were detected by primary screening techniques using modified starch casein agar medium. The active isolate was confirmed by various biochemical and morphological techniques.
In this study, 10 actinomycetes were isolated and later five were selected for secondary screening and noted significant activity against Enterobacter aerogenes and Proteus mirabilis. Among the selected Streptomyces sp., ES2 showed potent activity against selected microbes and was identified as Streptomyces sp. The studied isolates were resisitant towards streptomycin (10μg), ampicillin (50μg) and ciprofloxacin (5μg). The organic solvent extracts of the promising isolate ES2 prononunced comparatively better inhibitory properties towards the studied pathogenic bacteria.
Overall, the present study evidenced that the actinomycetes were promising candidate for the eradication of the pathogenic strains.
由于市售抗菌剂的广泛应用,耐药性传染病病原体引起的微生物病原体的发生得到了高度传播。然而,对微生物病原体的根除是非常需要的。尽管市场上有许多抗菌化合物,但病原体的传播却大大增加了。放线菌产生各种针对病原菌和真菌的次生代谢物。本研究旨在研究链霉菌属对引起传染病的病原体的抗菌潜力。
采用可培养的分离技术分离活性放线菌分离株,并通过使用改良淀粉酪蛋白琼脂培养基的初步筛选技术检测放线菌的抗菌特性。通过各种生化和形态学技术对活性分离株进行确认。
在这项研究中,分离出了 10 株放线菌,随后选择了 5 株进行二次筛选,并发现它们对产气肠杆菌和奇异变形杆菌具有显著的活性。在所选择的链霉菌属中,ES2 对选定的微生物表现出很强的活性,并被鉴定为链霉菌属。研究分离株对链霉素(10μg)、氨苄青霉素(50μg)和环丙沙星(5μg)有抗性。有前途的分离株 ES2 的有机溶剂提取物对研究的致病性细菌表现出较好的抑制特性。
总的来说,本研究表明放线菌是根除病原菌的有希望的候选者。